Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$21.0 - $29.1 $68,733 - $95,244
-3,273 Reduced 26.53%
9,065 $200,000
Q4 2023

Feb 01, 2024

SELL
$19.72 - $28.68 $27,115 - $39,435
-1,375 Reduced 10.03%
12,338 $339,000
Q3 2023

Nov 09, 2023

SELL
$22.33 - $29.92 $13,933 - $18,670
-624 Reduced 4.35%
13,713 $306,000
Q2 2023

Aug 29, 2023

SELL
$20.96 - $26.99 $13,079 - $16,841
-624 Reduced 4.17%
14,337 $365,000
Q1 2023

May 04, 2023

BUY
$20.58 - $27.89 $13,562 - $18,379
659 Added 4.61%
14,961 $333,000
Q4 2022

Feb 09, 2023

SELL
$15.31 - $29.94 $13,044 - $25,508
-852 Reduced 5.62%
14,302 $339,000
Q3 2022

Nov 07, 2022

BUY
$16.58 - $27.9 $14,457 - $24,328
872 Added 6.11%
15,154 $252,000
Q2 2022

Jul 13, 2022

SELL
$15.45 - $29.52 $23,113 - $44,161
-1,496 Reduced 9.48%
14,282 $284,000
Q1 2022

May 05, 2022

BUY
$21.94 - $42.51 $33,787 - $65,465
1,540 Added 10.82%
15,778 $435,000
Q4 2021

Jan 24, 2022

BUY
$36.09 - $53.79 $32,553 - $48,518
902 Added 6.76%
14,238 $587,000
Q3 2021

Oct 22, 2021

BUY
$35.62 - $52.97 $75,656 - $112,508
2,124 Added 18.94%
13,336 $619,000
Q2 2021

Jul 23, 2021

BUY
$32.94 - $56.62 $116,377 - $200,038
3,533 Added 46.01%
11,212 $448,000
Q1 2021

Apr 09, 2021

BUY
$44.47 - $81.38 $83,025 - $151,936
1,867 Added 32.12%
7,679 $413,000
Q4 2020

Feb 05, 2021

SELL
$32.49 - $61.88 $33,887 - $64,540
-1,043 Reduced 15.22%
5,812 $284,000
Q3 2020

Nov 06, 2020

BUY
$26.73 - $35.67 $183,234 - $244,517
6,855 New
6,855 $223,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Efg Asset Management (Americas) Corp. Portfolio

Follow Efg Asset Management (Americas) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.